Virtu Financial’s Acumen Pharmaceuticals ABOS Stock Holding History

Virtu Financial’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32K	Buy	+11,940	New	+$29.5K	﹤0.01%	1287
2026 Q1	–	Sell	-10,922	Closed	-$23K	–	1565
2025 Q4	$23K	Buy	+10,922	New	+$21.7K	﹤0.01%	1398
2024 Q4	–	Sell	-22,255	Closed	-$55K	–	1475
2024 Q3	$55K	Sell	22,255 -2,147	-9%	-$5.82K	﹤0.01%	997
2024 Q2	$59K	Buy	+24,402	New	+$77.7K	﹤0.01%	883
2024 Q1	–	Sell	-23,787	Closed	-$91K	–	1347
2023 Q4	$91K	Buy	+23,787	New	+$70.6K	0.01%	1049
2022 Q3	–	Sell	-26,204	Closed	-$123K	–	1663
2022 Q2	$123K	Buy	+26,204	New	+$98.4K	0.01%	892

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Virtu Financial's ABOS Position: Q2 2026 in Review

Virtu Financial opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 11,940 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #1287 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ABOS as recently as Q4 2025.

Virtu Financial first reported a position in ABOS in Q2 2022 and has held it in 6 quarters since. The position peaked at $123K in Q2 2022. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

Virtu Financial held 11,940 shares of Acumen Pharmaceuticals worth $32K as of Q2 2026.
Acumen Pharmaceuticals was a new Virtu Financial position in Q2 2026.
Acumen Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1287 holding.
Virtu Financial first reported a position in Acumen Pharmaceuticals in Q2 2022 and has held it in 6 quarters since.
Virtu Financial's Acumen Pharmaceuticals position peaked at $123K in Q2 2022.
96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.